✦ LIBER ✦

Blood pressure lowering, renin suppressing and natriuretic properties of a new designer peptide BD-NP

✍ Scribed by Ondrej Lisy; John G Lainchbury; John C Burnett

Book ID: 117599856
Publisher: Nature Publishing Group
Year: 2001
Tongue: English
Weight: 51 KB
Volume: 14
Category: Article
ISSN: 0895-7061
DOI: 10.1016/s0895-7061(01)01352-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

M-Atrial Natriuretic Peptide: A Novel De

M-Atrial Natriuretic Peptide: A Novel Designer Natriuretic Peptide with Sustained Blood Pressure Lowering and Cyclic GMP Activating Actions in a Chronic Canine Model of Angiotensin II-Induced Hypertension

✍ Puccia, Giuseppe; Sangaralingham, Sasantha J.; Harty, Gail; Cataliotti, Alessand 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 38 KB

Cenderitide (CD-NP), a novel peptide des

Cenderitide (CD-NP), a novel peptide designed to activate both guanylyl cyclase B and A, activates the second messenger cGMP, suppresses aldosterone, and preserves GFR without reducing blood pressure in a proof-of-concept study in patients with chronic heart failure

✍ Lisa C Costello-Boerrigter; John A Schirger; Wayne L Miller; Guido Boerrigter; H 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 135 KB

Costello-Boerrigter et al.: Cenderitide (CD-NP), a novel peptide designed to activate both guanylyl cyclase B and A, activates the second messenger cGMP, suppresses aldosterone, and preserves GFR without reducing blood pressure in a proof-of-concept study in patients with chronic heart failure.

CD-NP, A NOVEL PEPTIDE DESIGNED TO ACTIV

CD-NP, A NOVEL PEPTIDE DESIGNED TO ACTIVATE BOTH GUANYLYL CYCLASE B AND A, ACTIVATES THE SECOND MESSENGER CGMP, SUPPRESSES ALDOSTERONE AND PRESERVES GFR WITHOUT REDUCING BLOOD PRESSURE IN A PROOF-OF-CONCEPT STUDY IN PATIENTS WITH CHRONIC HEART FAILURE

✍ Elizabeth Costello; John A. Schirger; Guido Boerrigter; Horng H. Chen; Ruth Kemp 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 240 KB